GlassScriptPhysician profile
Adam M Branch
NPI 1942601497
$7,249.92
in general payments reported to CMS, 2019-2025
35 companies · $2,917 in 2025
The $2,917 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,252 · 2022: $864 · 2023: $1,580 · 2024: $636 · 2025: $2,917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,129 · Travel and Lodging: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,129.14 |
| Travel and Lodging | $1,004.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,793.19 | 2022-2025 | Inspire |
| Glaxosmithkline, LLC. | $1,275.29 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,255.43 | 2021-2025 | Fasenra, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $604.24 | 2021-2024 | Ofev |
| Mylan Specialty L.P. | $325.49 | 2021-2023 | Yupelri |
| Harmony Biosciences LLC | $219.56 | 2022-2024 | Wakix |
| Grifols USA, LLC | $215.23 | 2021-2025 | Prolastin-C Liquid |
| Insmed, INC. | $175.04 | 2021-2025 | Arikayce |
| Electromed, INC. | $138.88 | 2022-2025 | Smartvest |
| Janssen Pharmaceuticals, INC | $105.30 | 2021-2024 | Xarelto |
| Jazz Pharmaceuticals INC. | $101.47 | 2024-2025 | |
| Genzyme Corporation | $92.74 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $90.08 | 2025 | Dupixent |
| United Therapeutics Corporation | $74.26 | 2023 | Tyvaso |
| Baxter Healthcare | $68.86 | 2023-2024 | Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $62.60 | 2022-2024 | Entre Plus, Flexitouch Plus |
| Verona Pharma, INC. | $61.21 | 2025 | Ohtuvayre |
| Philips North America LLC | $56.32 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.48 | 2021 | |
| Gilead Sciences, INC. | $54.43 | 2023 | Veklury |
| Azurity Pharmaceuticals, INC. | $49.49 | 2024 | Horizant |
| Axsome Therapeutics, INC. | $45.22 | 2023-2025 | Sunosi |
| Novartis Pharmaceuticals Corporation | $41.70 | 2021-2025 | |
| Amgen INC. | $41.55 | 2024-2025 | Tezspire |
| Actelion Pharmaceuticals US, INC. | $31.69 | 2021 | |
| Itamar Medical INC | $31.42 | 2022-2023 | Watchpatone |
| Abbvie INC. | $27.41 | 2025 | |
| Viatris Specialty LLC | $24.34 | 2025 | Yupelri |
| Paratek Pharmaceuticals, INC. | $23.20 | 2023 | Nuzyra |
| Fisher & Paykel Healthcare INC | $23.00 | 2023 | Fisher & Paykel Healthcare |
| Advanced Respiratory, INC | $21.23 | 2021 | |
| Mallinckrodt Hospital Products INC. | $19.99 | 2025 | Acthar |
| Avadel Cns Pharmaceuticals, LLC | $17.63 | 2025 | Lumryz |
| Bayer Healthcare Pharmaceuticals INC. | $14.23 | 2021 | |
| Pulmonx Corporation | $12.72 | 2023 | Zephyr Delivery Catheter, Chartis Catheter, Zephyr Endobronchial Valve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Branch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.